Trends in Opioid Use over Time: 1997 to 1999

Journal of Palliative Medicine

Volumn 7, Issue 1, 2004, Pages 39-45

  Tolle, Susan W ^a   Hickman, Susan E ^a   Tilden, Virginia P ^a,b   Bubalo, Joseph S ^a   Fromme, Erik K ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FENTANYL; HYDROMORPHONE; METHADONE; MORPHINE; OPIATE; OXYCODONE; PETHIDINE; SUFENTANIL;

ADULT; ARTICLE; DRUG USE; DYING; FEMALE; HEALTH CARE QUALITY; HOSPITAL PATIENT; HUMAN; MALE; PAIN; PRESCRIPTION; TERMINAL CARE; UNITED STATES;

ANALGESICS, OPIOID; DATABASES; DRUG AND NARCOTIC CONTROL; DRUG UTILIZATION; HUMANS; LINEAR MODELS; MORPHINE; OREGON; PAIN; PALLIATIVE CARE; TERMINAL CARE; UNITED STATES;

EID: 1242264385     PISSN: 10966218     EISSN: None     Source Type: Journal    
DOI: 10.1089/109662104322737232     Document Type: Article

References (23)

1. Singer PA, Martin DK, Kelner M: Quality end-of-life care: Patients' perspectives. JAMA 1999;1281:163-168.
2. Doyle D, Hanks GWC, MacDonald N: Oxford Textbook of Palliative Medicine, 2nd ed. New York: Oxford University Press, 1998.
3. Jacox A, Carr DB, Payne R, et al: Management of Cancer Pain. Clinical Practice Guideline No. 9. AHCPR Publication No. 94-0592. Rockville, MD. Agency for Health Care Policy and Research, U.S. Department of Health and Human Services, Public Health Service, March 1994.
4. Bernabei R, Bambassi G, Lapane K, Landi F, Gatsonis C, Dunlop R, Lipsitz L, Stcel K, Mor V: Management of pain in elderly patients with cancer. SAGE Study Group: Systematic Assessment of Geriatric Drug Use via Epidemiology. JAMA 1998;279:1877-1882.
5. The SUPPORT Principal Investigators: A controlled trial to improve care for seriously ill hospitalized patients. JAMA 1995;274:1591-1598.
6. Joranson DE: Availability of opioids for cancer pain: Recent trends, assessment of system barriers, new World Health Organization Guidelines, and the risk of diversion. J Pain Symptom Manage 1993;8:353-360.
7. Steinbrook R: Physician-assisted suicide in Oregon - An uncertain future. N Engl J Med 2002;346:460-464.
8. Oregon Health & Science University. OHSU At A Glance Page. 〈www.ohsu.edu/about/glance/html〉 (Last accessed February 14, 2003).
9. Krames ES: Intrathecal infusional therapies for intractable pain: Patient management guidelines. J Pain Symptom Manage 1993;8:36-46.
10. Mercadante S: Problems of long-term spinal opioid treatment in advanced cancer patients. Pain 1999;79:1-13.
11. Office of Diversion Control. DADS Quarterly Reports. Arlington VA: US Department of Justice, 1999.
12. Anderson R, Saiers, JH, Abram S, Schlicht C: Accuracy in equianalgesic dosing: Conversion dilemmas. J Pain Symptom Manage 2001;21:397-406.
13. Pereira J, Lawlor P, Vigano A, Dorgan M, Bruera E: Equianalgesic dose ratios for opioids. A critical review and proposals for long-term dosing. J Pain Symptom Manage 2001;22:672-687.
14. Cohen J, Cohen P: Applied Multiple Regression/Correlation Analysis for the Behavioral Sciences. Hillsdale, New Jersey: Lawrence Earlbaum, 1975.
15. Ganzini L, Nelson HD, Lee MA, Kraemer DF, Schmidt TA, Delorit MA: Oregon physicians' attitudes about and experiences with end-of-life care since passage of the Oregon Death With Dignity Act. JAMA 2001;285:2363-2369.
16. Matesa J: A roundup of recent pain-policy avenues and trends. State Initiatives in End-of-Life Care 2002;14:6-8.
17. Tolle SW, Tilden VP, Hickman SE, Rosenfeld AG: Family reports of pain in dying hospitalized patients: a structured telephone survey. West J Med 2000;172:374-377.
18. Hickman SE, Tolle SW, Tilden VP: Physicians' and nurses' perspectives on increased family reports of pain in dying hospitalized patients. J Palliat Med 2000;3:413-418.
19. Tolle SW, Haley K: Pain management in the dying ... successes and concerns. Oregon Board of Medical Examiners Report 1998; Fall:1,4.
20. Joranson DE, Ryan KM, Gilson AM, Dahl JL: Trends in medical use and abuse of opioid analgesics. JAMA 2000;283:1710-1714.
21. Center for Evaluative Clinical Sciences (2000). The Dartmouth Atlas. Dartmouth University. 〈www. dartmouthatlas.org〉 (Last accessed May 1, 2003).
22. Lacy CF, Armstrong LL, Goldman MP, Lance LL: Drug Information Handbook, 7th ed. Hudson, OH: Lexicomp, Inc., 1999.
23. Janssen Pharmaceuticals: Duragesic, fentanyl transdermal system prescribing information. Titusville, NJ, 1994.